官方服务：
资源简介：
Identifying neoantigen associated T cell receptors in NSCLC: TRACERx Lung
应用场景：
创建时间：
2019-09-20
相关数据集
salivary microbiome and metabolites associated with immunotherapy efficacy in lung cancer
Lung cancer is a leading cause of cancer mortality, with NSCLC comprising the majority of cases. Despite the advent of immune checkpoint inhibitors(ICIs), a significant number of patients fail to achi
DataCite Commons2025-06-01 更新30
Table_1_De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma.xlsx
PurposeDespite the success of targeted therapy in c-ros oncogene 1 (ROS1)-rearranged cancers, especially non-small cell lung cancer (NSCLC), the clinical significance of ROS1 de novo mutation has not
NIAID Data Ecosystem10
Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment. Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment
We present a pan-cancer integrated analysis of transcriptome, exome and clinical records of patients. Herein, we identified candidate genes as potential biomarkers to predict clinical outcome of immun
NIAID Data Ecosystem10
PD-L1 expression as predictor of immunotherapy eligibility in penile squamous cell carcinoma patients.xlsx
PD-L1 is a tumor marker that co-stimulates the receptor PD-1 to suppress T-cell-mediated antitumor immunity. Seventy-six biopsy sample were taken from patients diagnosed with penile squamous cell carc
NIAID Data Ecosystem20
Table_1_TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.pdf
Translational research on immune checkpoint inhibitors (ICIs) has been underway. However, in the unselected population, only a few patients benefit from ICIs. Therefore, screening predictive markers o
NIAID Data Ecosystem10
